bpc 157 human clinical trials status 2025 Eleven that will shape medicine in BPC-157 as a Healing Peptide

Strong evidence, from decades of treating individuals with inborn errors of B 12 metabolism, supports the safety of parenteral, lifelong, even high dose hydroxocobalamin, sometimes even at very high doses.6768 Long term epidemiological studies also indicate that treatment with pharmacological B 12 doses and the corresponding increase in serum B 12 do not increase mortality.69 Data on the safety of cyanocobalamin, when administered with high frequency (ie, one to two times a week) for a longer period of time, are lacking

Sanyal A, Ghosh A, Roy C, et al

TB-500 (Thymosin Beta-4 fragment) TB-500 is a synthetic analogue of the naturally occurring peptide Thymosin Beta-4

Therefore, we performed pharmacokinetic studies of BPC157 in beagle dogs following single IV administration at a dose of 6 g/kg, single IM administration at doses of 6, 30, or 150 g/kg, and repeated IM administration at a dose of 30 g/kg for seven consecutive days